News
News
Academy
Multimedia
Editorial PodcastsEditorial VideosPeer ExchangeProfiles in Medicine
Conferences
Conference CoverageConference Listing
More
Publications
Pharmaceutical Executive
Partner Perspectives
Resources
Content Engagement HubsE-BooksEventsSponsored PodcastsSponsored VideosWebcastsWhitepapers

Subscribe

  • News
  • Academy
  • Multimedia
  • Conferences
  • Publications
  • Partner Perspectives
  • Resources
  • Subscribe
  • Corporate Communications
    • Press Releases
    • Executive Roundtable
    • Executive Profiles
    • Leadership
  • Direct-to-Consumer
    • Patient Education
    • Healthcare Access
    • Telehealth
  • Emerging Biopharma
    • Partnerships
    • Funding
  • IR Licensing and Partnerships
    • Finance
    • Industry Trends
  • Market Access
    • Patient Access
    • Pricing
    • Strategy
  • Medical Affairs
    • Patient Advocacy
    • Clinical Data
    • Pharmacovigilance
  • Operations
    • Sustainability
    • Technology
    • R&D/Clinical Trials
    • Supply Chain
  • Patient Engagement
    • DE&I
  • Regulatory
    • FDA
    • Legal
    • Global
  • Sales & Marketing
    • Sales Effectiveness
    • Campaigns
    • DTC Marketing
    • Medical Education
Spotlight -
Asembia 2025 |
Sales Effectiveness|
Latest Executive Roundtables
Advertisement
|Articles|November 20, 2007

Matthew Kurtz

Advertisement

Matthew Kurtz, Regional Sales Manager

T: (212) 951-6751
F: (212) 951-6604
mkurtz@advanstar.com


Covers New York, New Jersey, and international outside Canada

Newsletter

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Subscribe Now!
Advertisement

Related Content

Advertisement
Stock.adobe.com

Merck to Acquire Cidara for $9.2 Billion

ByMike Hollan
November 14th 2025

Invictus Pharmacy Becomes First US Pharmacy to Accept Cryptocurrency for Prescriptions

ByNicholas Saraceno, Editor
November 14th 2025
Image Credit: Adobe Stock Images/Grandbrothers

Komzifti Gains FDA Approval, Giving Kura Oncology and Kyowa Kirin a Key Strategic Win in NPM1-Mutated AML

ByDavy James
November 14th 2025
Pharmaceutical Executive

Pharmaceutical Executive Daily: WeightWatchers Planning to Offer Wegovy Following Approval

ByNicholas Jacobus
November 14th 2025
Craig Ackerman

How Are Executives Adapting Their Growth Strategies to the Current Environment?

ByMike Hollan,Craig Ackerman
November 14th 2025
Advertisement
Advertisement

Trending on PharmExec

1

The Influence of Targeting CCR5 Receptors

2

Merck to Acquire Cidara for $9.2 Billion

3

Komzifti Gains FDA Approval, Giving Kura Oncology and Kyowa Kirin a Key Strategic Win in NPM1-Mutated AML

4

DEI Changes in Pharma: A Look Back at 2025 & Predictions for 2026

5

Pharmaceutical Executive Daily: WeightWatchers Planning to Offer Wegovy Following Approval

  • About
  • Advertise
  • Contact Us
  • Editorial Board
  • Editorial Submission Guidelines
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us